Human Vaccine Market

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Human Vaccine Market contains market size and forecasts of Human Vaccine in global, including the following market information:

• Global Human Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Human Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
• Global top five Human Vaccine companies in 2021 (%)

The global Human Vaccine market was valued at 32870 million in 2021 and is projected to reach US$ 44570 million by 2028, at a CAGR of 4.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Varicella Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Vaccine include CNBG, Changsheng Life, Zhifei, ChengDa Bio, Kangtai, SINOVAC BIOTECH, Hissen, Walvax Biotechnology and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Human Vaccine Market Segment Percentages, by Type, 2021 (%)

• Varicella
• Influenza
• Polio
• Hepatitis A
• Rabies
• BCG
• Hepatitis B
• Pertussis, Diphtheria, Tetanus
• Pneumococcal
• Rota vaccine

Global Human Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Human Vaccine Market Segment Percentages, by Application, 2021 (%)

• Adults
• Children

Global Human Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Human Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Human Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Human Vaccine revenues share in global market, 2021 (%)
• Key companies Human Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
• Key companies Human Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CNBG
• Changsheng Life
• Zhifei
• ChengDa Bio
• Kangtai
• SINOVAC BIOTECH
• Hissen
• Walvax Biotechnology
• GSK
• SANOFI
• Rong An
• NuoCheng Bio
• Hualan Bio
• Tiantan biological
• Changchun Baike
• Adimmune
• Zhongyianke Biotech
• Bharat Biotech
• Bavarian Nordic
• Sanofi-Pasteur
• Indian Immunologicals
• KANGH
• Henan Grand Biopharma
• ZhongKe Biopharm
• Zhuoyi Biological